Panzyga
NDC Package 68982-820-04
Package Information
Panzyga is a medication used to strengthen the body's natural defense system (immune system) to lower the risk of infection in persons with a weakened immune system. Marketed by Octapharma Usa Inc, this product is identified by NDC 68982-820 and is authorized under FDA application BLA125587.
Identification & Billing
- RxCUI: 2102435 - immune globulin intravenous (human) - ifas 10 % in 10 ML Injection
- RxCUI: 2102435 - 10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection
- RxCUI: 2102435 - immune globulin intravenous (human) - ifas 10 % per 10 ML Injection
- RxCUI: 2102440 - panzyga 10 % in 10 ML Injection
- RxCUI: 2102440 - 10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68982 - Octapharma Usa Inc
- 68982-820 - Panzyga
- 68982-820-04 - 1 BOTTLE, GLASS in 1 CARTON / 100 mL in 1 BOTTLE, GLASS (68982-820-84)
- 68982-820 - Panzyga
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68982-820). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68982-820-04 identifies a specific commercial package of 1 bottle, glass in 1 carton / 100 ml in 1 bottle, glass (68982-820-84) of Panzyga, labeled by Octapharma Usa Inc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Octapharma Usa Inc on November 12, 2018. The current certification is valid through December 31, 2022.
What are the primary indications for this medication?
This medication is used to strengthen the body's natural defense system (immune system) to lower the risk of infection in persons with a weakened immune system. This medication is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections. It is also used to increase the blood count (platelets) in persons with a certain blood disorder (idiopathic thrombocytopenia purpura-ITP). Platelets are needed to stop bleeding and form blood clots. Some immune globulin products may also be used to treat a certain type of muscle weakness problem (multifocal motor neuropathy) or a certain nerve disorder (chronic inflammatory demyelinating polyneuropathy-CIDP). Some products may also be used to prevent certain blood vessel disorders in people with Kawasaki syndrome.
How is this Octapharma Usa Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68982082004. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
